NKGen Biotech, Inc. (NKGN)
OTCMKTS · Delayed Price · Currency is USD
0.1600
+0.1000 (166.67%)
Apr 13, 2026, 10:01 AM EST
NKGen Biotech Market Cap
NKGen Biotech has a market cap or net worth of $7.84 million as of April 15, 2026. Its market cap has decreased by -52.76% in one year.
Market Cap
7.84M
Enterprise Value
46.02M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.16
Market Cap Chart
Since August 4, 2023, NKGen Biotech's market cap has decreased from 338.09M to 7.84M, a decrease of -97.68%. That is a compound annual growth rate of -75.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 7.84M | 26.01% |
| Dec 31, 2025 | 6.22M | -73.65% |
| Dec 31, 2024 | 23.60M | -60.80% |
| Dec 29, 2023 | 60.19M | -82.20% |
| Aug 4, 2023 | 338.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Finch Therapeutics Group | 11.88M |
| TRON Group | 9.57M |
| Brainstorm Cell Therapeutics | 9.56M |
| ZIVO Bioscience | 8.80M |
| Curative Biotechnology | 7.32M |
| Synlogic | 7.25M |
| BetterLife Pharma | 6.29M |
| Nymox Pharmaceutical | 6.12M |